NDC 59267-1404

Pfizer-BioNTech Covid-19 Vaccine, Bivalent

Bnt162b2 Original And Omicron Ba.4/ba.5

Pfizer-BioNTech Covid-19 Vaccine, Bivalent is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Pfizer Manufacturing Belgium Nv. The primary component is Bnt162b2 Omicron (ba.4/ba.5); Tozinameran.

Product ID59267-1404_56766f7a-d588-41c6-93bb-0f602a7fc1ef
NDC59267-1404
Product TypeVaccine
Proprietary NamePfizer-BioNTech Covid-19 Vaccine, Bivalent
Generic NameBnt162b2 Original And Omicron Ba.4/ba.5
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-09-01
Marketing CategoryEMERGENCY USE AUTHORIZATION /
Labeler NamePfizer Manufacturing Belgium NV
Substance NameBNT162B2 OMICRON (BA.4/BA.5); TOZINAMERAN
Active Ingredient Strength0 mg/.48mL; mg/.48mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 59267-1404-2

10 VIAL, GLASS in 1 CARTON (59267-1404-2) > .48 mL in 1 VIAL, GLASS (59267-1404-1)
Marketing Start Date2022-09-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pfizer-BioNTech Covid-19 Vaccine, Bivalent" or generic name "Bnt162b2 Original And Omicron Ba.4/ba.5"

NDCBrand NameGeneric Name
59267-0304Pfizer-BioNTech Covid-19 Vaccine, BivalentBNT162b2 Original and Omicron BA.4/BA.5
59267-0565Pfizer-BioNTech Covid-19 Vaccine, BivalentOriginal and Omicron BA.4/BA.5
59267-0609Pfizer-BioNTech Covid-19 Vaccine, BivalentOriginal and Omicron BA.4/BA.5
59267-1404Pfizer-BioNTech Covid-19 Vaccine, BivalentBNT162b2 Original and Omicron BA.4/BA.5

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.